metricas
covid
Buscar en
Archivos de la Sociedad Española de Oftalmología (English Edition)
Toda la web
Inicio Archivos de la Sociedad Española de Oftalmología (English Edition) Intravitreal ranibizumab in the treatment of subretinal neovascularization in a ...
Journal Information
Vol. 89. Issue 3.
Pages 130-132 (March 2014)
Share
Share
Download PDF
More article options
Visits
1636
Vol. 89. Issue 3.
Pages 130-132 (March 2014)
Short communication
Intravitreal ranibizumab in the treatment of subretinal neovascularization in a case of punctate inner choroidopathy
Ranibizumab intravítreo en el tratamiento de membrana neovascular subretiniana en un caso de coroidopatía puntata interna
Visits
1636
B. Jiménez
Corresponding author
bea83jdm@hotmail.com

Corresponding author.
, I. Pinilla, J.A. Cristóbal, E. Mínguez, D. Pérez, N. Cruz, C. Peiro
Servicio de Oftalmología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (4)
Show moreShow less
Abstract
Case report

We report the case of a 28-year-old woman suffering from loss of visual acuity in her left eye, who presented an image suggestive of a subretinal neovascular membrane in her left eye, and bilateral retinal lesions compatible with punctate inner choroidopathy (PIC). She was treated with intravitreal ranibizumab obtaining excellent results.

Discussion

The differential diagnosis must be made between PIC and the rest of “white dot syndromes” and the presumed ocular histoplasmosis syndrome (POHS). Antiangiogenic drugs may be a good alternative for the treatment of such diseases when they develop a subretinal neovascular membrane.

Keywords:
Punctate inner choroidopathy
Neovascular membrane
Fluorescein angiography
Angiogenesis inhibitors
Ranibizumab
Resumen
Caso clínico

Se presenta el caso de una mujer de 28 años con disminución de agudeza visual en ojo izquierdo (OI) que presentaba una imagen sugestiva de membrana neovascular subretiniana en OI y lesiones coriorretinianas bilaterales compatibles con coroidopatía punctata interna (PIC) que fue tratada con ranibizumab intravítreo, obteniendo excelentes resultados.

Discusión

Debe realizarse el diagnóstico diferencial de la PIC con el resto de «síndromes de puntos blancos» y con el síndrome de presunta histoplasmosis ocular (SPHO). Los fármacos anti-VEGF pueden ser una buena alternativa como tratamiento de este tipo de enfermedades cuando desarrollan una membrana neovascular subretiniana.

Palabras clave:
Coroidopatía punctata interna
Membrana neovascular
Angiografía fluoresceínica
Antiangiogénicos
Ranibizumab

Article

These are the options to access the full texts of the publication Archivos de la Sociedad Española de Oftalmología (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Archivos de la Sociedad Española de Oftalmología (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos